Results 1 to 10 of about 6,497 (208)
Some of the next articles are maybe not open access.
American Cancer Society prostate cancer survivorship care guidelines
Ca-A Cancer Journal for Clinicians, 2014Michael Zelefsky, Jeanny Aragon-Ching
exaly
Prostate Specific Antigen Working Group Guidelines on Prostate Specific Antigen Doubling Time
Journal of Urology, 2008Philip Kantoff, Michael W Kattan
exaly
American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
Ca-A Cancer Journal for Clinicians, 2010Robert Volk +2 more
exaly
Optimal prostate-specific antigen screening interval for prostate cancer
Annals of Oncology, 2012Paul P
exaly
The contemporary management of prostate cancer
Ca-A Cancer Journal for CliniciansAlison Reid, Jochen Walz
exaly
Prostate cancer statistics, 2025
Ca-A Cancer Journal for CliniciansWilliam Dahut, Tyler Kratzer
exaly
Journal of Pathology of Nepal, 2022 Background: Prostate-specific antigen density has been suggested to enhance the diagnostic efficacy of serum prostate-specific antigen alone in detecting prostate cancer, thereby reducing unnecessary biopsies and associated morbidities.
Reshmi Shrestha +3 more
doaj +1 more source
Seminars in Surgical Oncology, 2000 Prostate-specific antigen (PSA) has revolutionized the diagnosis and management of men with prostate cancer. Significant advances have been made since the early development of immunoassays. While PSA is useful for staging and monitoring of established disease, it has shown the greatest utility in the realm of early detection realm.
D K, Ornstein, R S, Pruthi
+8 more sources